Clinical Evidence for the Benefits of Burosumab Therapy for X-Linked Hypophosphatemia (XLH) and Other Conditions in Adults and Children
Author:
Publisher
Frontiers Media SA
Subject
Endocrinology, Diabetes and Metabolism
Reference25 articles.
1. Regulation of FGF signaling: Recent insights from studying positive and negative modulators;Korsensky;Semin Cell Dev Biol.,2016
2. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23;Nat Genet.,2000
3. Endocrine functions of bone in mineral metabolism regulation;Quarles;J Clin Invest.,2008
4. Expression and cloning of the human X-linked hypophosphatemia gene cDNA;Grieff;Biochem Biophys Res Commun.,1997
5. Therapeutic management of hypophosphatemic rickets from infancy to adulthood;Linglart;Endocr Connect.,2014
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Endocrine fibroblast growth factors in domestic animals;Domestic Animal Endocrinology;2024-10
2. Burosumab Efficacy and Safety in Patients with X-Linked Hypophosphatemia: Systematic Review and Meta-analysis of Real-World Data;Calcified Tissue International;2024-07-15
3. Lessons learned from the real-world diagnosis and management of hereditary hypophosphatemic rickets;Bone Reports;2024-06
4. Characteristics of oral health of patients with X-linked hypophosphatemia: case reports and literature review;BDJ Open;2024-05-31
5. Real‐world data of Brazilian adults with X‐linked hypophosphatemia (XLH) treated with burosumab and comparison with other worldwide cohorts;Molecular Genetics & Genomic Medicine;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3